Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Colorectal Liver Metastasis Clinical Trial

Official title:
Minimally Invasive(Laparoscopic and Robotic) Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases

Status Recruiting

Clinical Trial Summary

To examine survival of patients who underwent minimally invasive versus open liver resection for colorectal cancer with liver metastases.

the minimally invasive procedure contain laparoscopic or robotic surgery ;

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02642978` - Robot-assisted Procedure Versus Open Simultaneous Resection of Colorectal Cancer With Liver Metastases	N/A
Active, not recruiting	`NCT02399995` - Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over Time
Active, not recruiting	`NCT04751773` - Postoperative Exercise Training in Patients With Colorectal Liver Metastases Undergoing Surgery (ELMA)	N/A
Completed	`NCT01523353` - Prehabilitation in Liver Surgery	Phase 1
Recruiting	`NCT04678583` - Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer	N/A
Completed	`NCT02727179` - Open vs Laparoscopic Liver Surgery for Colorectal Liver Metastases	N/A
Recruiting	`NCT05753163` - Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study	Phase 2